| Title |
Therapeutic insulins and their large-scale manufacture
|
|---|---|
| Published in |
Applied Microbiology and Biotechnology, December 2004
|
| DOI | 10.1007/s00253-004-1809-x |
| Pubmed ID | |
| Authors |
Gary Walsh |
| Abstract |
Biotechnological innovations over the past 25 years have underpinned the rapid development of a thriving biopharmaceutical sector. Therapeutic insulin remains one of the most commonly used products of pharmaceutical biotechnology and insulin-based products command annual global sales in excess of $4.5 billion. Innovations in its method of production and in particular the advent of engineered insulin analogues provide a fascinating insight into how scientific and technological advances have impacted upon the pharmaceutical biotechnology sector as a whole. Current insulin-based diabetes research is increasingly focused not on the insulin molecule per se, but upon areas such as the development of non-parenteral insulin delivery systems, as well as organ-/cell-based and gene therapy-based approaches to controlling the disease. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 358 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | <1% |
| Denmark | 2 | <1% |
| United Kingdom | 2 | <1% |
| Germany | 1 | <1% |
| Italy | 1 | <1% |
| Austria | 1 | <1% |
| Poland | 1 | <1% |
| Unknown | 347 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 89 | 25% |
| Student > Master | 55 | 15% |
| Student > Ph. D. Student | 47 | 13% |
| Researcher | 32 | 9% |
| Student > Doctoral Student | 16 | 4% |
| Other | 46 | 13% |
| Unknown | 73 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 82 | 23% |
| Agricultural and Biological Sciences | 60 | 17% |
| Engineering | 31 | 9% |
| Chemistry | 31 | 9% |
| Chemical Engineering | 21 | 6% |
| Other | 53 | 15% |
| Unknown | 80 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2023.
All research outputs
#1,242,422
of 24,119,703 outputs
Outputs from Applied Microbiology and Biotechnology
#57
of 8,034 outputs
Outputs of similar age
#2,564
of 146,199 outputs
Outputs of similar age from Applied Microbiology and Biotechnology
#1
of 49 outputs
Altmetric has tracked 24,119,703 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,034 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 146,199 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.